Experimental treatment of neuroblastoma using [131I]meta-iodobenzylguanidine and topotecan in combination

A. McCluskey, Marie Boyd, S.L. Pimlott, J.W. Babich, M.N. Gaze, R.J. Mairs

Research output: Contribution to journal › Article › peer-review

30 Citations (Scopus)

Filter

2014
Dose calculations for [(131)i] meta-iodobenzylguanidine-induced bystander effects
Gow, M. D., Seymour, C. B., Mairs, R. J., Boyd, M., Prestiwch, W. V. & Mothersill, C. E., Jan 2014, In: Dose-response : a publication of International Hormesis Society. 12, 1, p. 1-23 23 p.
Research output: Contribution to journal › Article › peer-review
5 Citations (Scopus)
2013
The role of copper in disulfiram-induced toxicity and radiosensitisation of cancer cells.
Rae, C., Tesson, M., Babich, J. W., Boyd, M., Sorensen, A. & Mairs, R. J., 2013, (Accepted/In press) In: The Journal of Nuclear Medicine. 8 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
104 Downloads (Pure)
2008
Experimental targeted therapy using [211At]meta-astatobenzylguanidine and transfection of the noradrenaline transporter gene
Boyd, M., McCluskey, A. G., Sorensen, A. & Mairs, R. J., 1 Jun 2008, In: Current Radiopharmaceuticals. 1, 3, p. 197-202 6 p.
Research output: Contribution to journal › Article › peer-review

Research output